Back to Agenda
Session 4 Track C/E: Demonstrating and Communicating the Value of Medicines Through Health Economic and Outcomes Evidence
Session Chair(s)
Donna Wartski
Medical Outcomes Specialist
Pfizer, United States
Darryl L'Heureux, PhD, MPharm, MSc
Director, Clinical Science, Medical Writing, and Publications
Ambrx, Inc, United States
The reimbursement landscape has elevated the importance of health economics and outcomes research (HEOR) within the pharmaceutical industry. Demands from payers, population health decision makers, and payment models that incentivize quality have placed higher demands on the data provided and the importance of market access. In addition to clinical attributes such as safety and efficacy, there is an increased demand for evidence supporting the real world use of a drug, including patient experience, medication adherence, comparative effectiveness, and cost implications. It is essential for medical communicators working on any HEOR-related work to understand the role of that work within the context of the value proposition. Furthermore, field medical colleagues such as medical liaisons and outcomes liaisons play an important role in communicating this information to payers to inform their formulary decisions and quality initiatives.
Learning Objective : At the conclusion of this session, participants should be able to:
- Review the external regulatory and health care landscape
- Describe the scope of health pharmacoeconomic research and the differences from clinical trials
- Discuss why health outcomes and pharmacoeconomics data are important to payer customers and how they use this information
- Examine effective medical communication techniques and tools utilized by field medical colleagues
Speaker(s)
Demonstrating Value of Medicines Through Health Economic and Outcomes Evidence
Eleni Allen, PharmD
Amgen Inc., United States
Senior Manager, REMS Program Management (RPM)
Communicating the Value of Medicines to Payer Customers
Christopher Marrone, PharmD, RPh
Eli Lilly and Company, United States
Outcomes Liaison Advisor – National Accounts, Value, Evidence and Outcomes (VEO)
Customer Insight
Richard Montgomery
Adventist Health System, United States
Contracts and Operations Manager- Pharmacy
Have an account?